|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
Address1 | 25 MASSACHUSETTS AVENUE, NW |
Address2 | SUITE 600 |
City | WASHINGTON |
State | DC |
Zip Code | 20001-7400 |
Country | USA |
3. Principal place of business (if different than line 2)
City | Chicago |
State | IL |
Zip Code | 60611-5885 |
Country | USA |
|
5. Senate ID# 2877-12
|
||||||||
|
6. House ID# 304640000
|
TYPE OF REPORT | 8. Year | 2019 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
10. Check if this is a Termination Report | Termination Date |
|
11. No Lobbying Issue Activity |
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
---|---|---|---|---|---|---|---|---|---|
12. Lobbying | 13. Organizations | ||||||||
INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
Signature | Digitally Signed By: George E. Cox III, JD |
Date | 10/21/2019 7:43:43 AM |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code BUD
16. Specific lobbying issues
FY 2020 Labor-HHS-Education Funding Bill, provisions relating to gun violence research funding, and Title X
H.R. 2500, FY 2020 National Defense Authorization Act (NDAA), provisions in Section 716
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Richard |
Deem |
|
|
|
Cynthia |
Brown |
|
|
|
Todd |
Askew |
|
|
|
Dana |
Lichtenberg |
|
|
|
Andrew |
Wankum |
|
|
|
George |
Cox |
III |
|
|
Debra |
Cohn |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
H.R. 3502, Protecting People From Surprise Medical Bills Act, all provisions
H.R. 3630, No Surprises Act, all provisions
H.R. 2328, Community Health Investment, Modernization, and Excellence Act of 2019, all provisions
S.1531 - Stopping The Outrageous Practice of Surprise Medical Bills Act of 2019, all provisions
S. 1895, Lower Health Care Costs Act, provisions relating to unanticipated billing for physician services, private contracting, rate setting
H.R. 2279, Safe Step Act, all provisions
H.R.1503, Orange Book Transparency Act of 2019, all provisions
H.R.1520, Purple Book Continuity Act of 2019, all provisions
H.R.987, Strengthening Health Care and Lowering Prescription Drug Costs Act, all provisions
H.R.2482, Mainstreaming Addiction Treatment (MAT) Act of 2019, all provisions
S.2032, Cannabidiol and Marihuana Research Expansion Act all provisions
H.R. 8, Bipartisan Background Checks Act of 2019, all provisions
Affordable Care Act (ACA) stabilization
21st Century Cures Act
Surprise Billing/Independent dispute resolution (IDR)
Health Data Privacy regulation
Drug Prices
Maternal Mortality and Healthcare Disparity
Information blocking and interoperability
Health reform/universal coverage
Opioids/Substance use disorder
Universal background checks for commercial gun purchases
Health IT - Patient privacy, 42 CFR Part 2, HIPAA
Telehealth
Data privacy
Supplemental Nutrition Assistance Program (SNAP) and the National School Lunch Program
Section 1557 non-discrimination
Misvalued codes
Drug Compounding
Clinical Laboratory/Laboratory developed tests (LDTs)
Healthcare artificial/augmented intelligence (AI)
Radiopharmaceuticals/training and experience requirements
Gun violence
Confidentiality of Substance Use Disorder Patient Records/comment period extension
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Health & Human Services - Dept of (HHS), Federal Trade Commission (FTC), Centers For Disease Control & Prevention (CDC), Food & Drug Administration (FDA), President of the U.S., White House Office, Nuclear Regulatory Commission (NRC)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Richard |
Deem |
|
|
|
Cynthia |
Brown |
|
|
|
Todd |
Askew |
|
|
|
Lindsey |
Brill |
|
|
|
Dana |
Lichtenberg |
|
|
|
Jason |
Marino |
|
|
|
Chase |
Thomas |
|
|
|
Andrew |
Wankum |
|
|
|
Margaret |
Garikes |
|
|
|
Shannon |
Curtis |
|
|
|
Laura |
Hoffman |
|
|
|
Sandy |
Marks |
|
|
|
Matthew |
Reid |
|
|
|
Koryn |
Rubin |
|
|
|
Jason |
Scull |
|
|
|
George |
Cox |
III |
|
|
Jennifer |
Brown |
|
|
|
Debra |
Cohn |
|
|
|
Sylvia |
Trujillo |
|
|
|
Paul |
Westfall |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code IMM
16. Specific lobbying issues
H.R. 2895, Conrad State 30 and Physician Access Reauthorization Act, all provisions
S. 948, Conrad State 30 and Physician Access Reauthorization Act, all provisions
H.R. 3239, the Humanitarian Standards for Individuals in Customs and Border Protection Custody Act, all provisions
H.R. 6, American Dream and Promise Act of 2019, all provisions
S. 874, Dream Act of 2019, all provisions
Policy change/non-military deferred action requests at field offices
Mental health needs of children in HHS custody
Inhumane treatment at the border/child separation policy
Asylum-seekers/medically-appropriate care
Immigration and detention facilities
J-1 visa grace period/bankruptcy of Hahnemann University Hospital
17. House(s) of Congress and Federal agencies Check if None
Homeland Security - Dept of (DHS), U.S. Citizenship & Immigration Services (USCIS), U.S. Customs & Border Protection, U.S. Commission on Civil Rights, Health & Human Services - Dept of (HHS), Government Accountability Office (GAO), State - Dept of (DOS), Centers For Medicare and Medicaid Services (CMS)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Richard |
Deem |
|
|
|
Cynthia |
Brown |
|
|
|
Todd |
Askew |
|
|
|
Jason |
Marino |
|
|
|
Margaret |
Garikes |
|
|
|
Jason |
Scull |
|
|
|
George |
Cox |
III |
|
|
Jennifer |
Brown |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code LBR
16. Specific lobbying issues
Competition in the health insurance industry
Physician self-employment
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Richard |
Deem |
|
|
|
Cynthia |
Brown |
|
|
|
Todd |
Askew |
|
|
|
Chase |
Thomas |
|
|
|
Andrew |
Wankum |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
H.R. 3, Lower Drug Costs Now Act of 2019, provisions relating to increasing drug pricing transparency, incorporating value into drug pricing, reducing prior authorization burdens, physician samples
H.R. 3107, Improving Seniors' Timely Access to Care Act of 2019, all provisions
H.R. 1948, Lymphedema Treatment Act of 2019, all provisions
S. 518, Lymphedema Treatment Act, all provisions
H.R. 1358, Advancing Medical Resident Training in Community Hospitals Act of 2019, all provisions
S. 348, Resident Physician Shortage Reduction Act of 2019, all provisions
S. 595, Treat and Reduce Obesity Act of 2019, all provisions
Medicare program: Medicare Care Coordination Improvement Act
Medicare program: Physician Payment and delivery reform issues
Medicare program: Medicare Advantage
Medicare program: Quality Payment Program
Medicare program: Open Payments Program
Medicare program: Part D
Medicare program: Prescription drug costs
Medicare program: Merit-Based Incentive Payment System (MIPS)
Medicare program: Promoting interoperability
Medicare program: Regulatory Relief
Medicare program: Alternative Payment Models (APMs)
Medicare program: MACRA cost measure development
Medicare program: Stark modernization and utilization management
Medicare program: Accountable Care Organizations (ACOs)
Medicare program: Physician-Focused Payment Model Technical Advisory Committee (PTAC)
Medicare program: Medicare for All
Medicare program: Pharmacy Benefits Manager (PBM)/Rx drug price transparency
Medicare program: Patient Access
Medicare program: Evaluation and Management(E/M) services - global surgical services
Medicare program: Bankruptcy of Hahnemann University Hospital/waivers for residents and fellows
Medicare and Medicaid programs: Medicare Access and CHIP Reauthorization Act (MACRA) implementation/technical improvements
Medicare program: Diabetes Prevention Program
Medicare program: Provider Enrollment, Chain, and Ownership System (PECOS) Enrollment/Revalidation
Medicare and Medicaid programs: 21st Century Cures Act
Medicare and Medicaid programs: Health IT burden
Medicare and Medicaid programs: Prior authorization
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Centers For Medicare and Medicaid Services (CMS), Health & Human Services - Dept of (HHS)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Richard |
Deem |
|
|
|
Cynthia |
Brown |
|
|
|
Todd |
Askew |
|
|
|
Lindsey |
Brill |
|
|
|
Dana |
Lichtenberg |
|
|
|
Jason |
Marino |
|
|
|
Chase |
Thomas |
|
|
|
Andrew |
Wankum |
|
|
|
Margaret |
Garikes |
|
|
|
Shannon |
Curtis |
|
|
|
Jennifer |
McLaughlin |
|
|
|
Matthew |
Reid |
|
|
|
Koryn |
Rubin |
|
|
|
Laura |
Hoffman |
|
|
|
Sandy |
Marks |
|
|
|
Jennifer |
McLaughlin |
|
|
|
Matthew |
Reid |
|
|
|
Koryn |
Rubin |
|
|
|
Jason |
Scull |
|
|
|
George |
Cox |
III |
|
|
Jennifer |
Brown |
|
|
|
Debra |
Cohn |
|
|
|
Sylvia |
Trujillo |
|
|
|
Paul |
Westfall |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code VET
16. Specific lobbying issues
Military Health System/GME programs
Proposed reductions in uniformed medical positions
Veterans Choice/community Care Program
Scope of Practice
Tricare Access
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Defense - Dept of (DOD), Veterans Affairs - Dept of (VA)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Richard |
Deem |
|
|
|
Cynthia |
Brown |
|
|
|
Margaret |
Garikes |
|
|
|
Jason |
Scull |
|
|
|
George |
Cox |
III |
|
|
Jennifer |
Brown |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
Address |
|
||||||
City |
|
State |
|
Zip Code |
|
Country |
|
21. Client new principal place of business (if different than line 20)
City |
|
State |
|
Zip Code |
|
Country |
|
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
1 |
|
3 |
|
||||||
2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
TOB |
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% |
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
1 | 3 | 5 |
2 | 4 | 6 |
CONVICTIONS DISCLOSURE
29. Have any of the lobbyists listed on this report been convicted in a Federal or State Court of an offense involving bribery,
extortion, embezzlement, an illegal kickback, tax evasion, fraud, a conflict of interest, making a false statement, perjury, or money laundering?
Lobbyist Name | Description of Offense(s) |